News

C3 AI Reports Robust Growth in Q2 2025 Financial Results

C3 AI Reports Robust Growth in Q2 2025 Financial Results

Strong Performance in Fiscal Second Quarter 2025

C3.ai, Inc. (NYSE: AI), a leader in AI application software, recently declared its financial results for the fiscal second quarter, demonstrating substantial growth and resilience in a rapidly evolving market.

Quarterly Financial Highlights

In the latest quarter, C3 AI achieved total revenue of $94.3 million, reflecting a remarkable 29% increase from $73.2 million compared to the same period last year. This impressive performance underscores the company's robust market strategy and commitment to expanding its footprint in the enterprise AI sector.

Revenue Breakdown

Subscription revenue has made a significant contribution, amounting to $81.2 million, which constitutes 86% of total revenue. This marks a 22% increase year-over-year compared to $66.4 million. Moreover, the combined revenue from subscriptions and prioritized engineering services reached $90.8 million, illustrating a 27% growth when compared to $71.3 million in the previous year.

Profit Margins and Financial Health

C3 AI reported a GAAP gross profit of $57.8 million, showcasing a solid gross margin of 61%, with non-GAAP gross profit increasing to $66.3 million, corresponding to a non-GAAP gross margin of 70%. Despite these positive figures, the company recorded a GAAP net loss per share of $(0.52) and a non-GAAP net loss per share of $(0.06), reflecting ongoing strategic investments and growth initiatives.

Strategic Alliances Driving Growth

The partnership with Microsoft continues to be a catalyst for C3 AI’s development, establishing the company as a preferred AI application provider on the Azure platform. This strategic collaboration aims to streamline the adoption and deployment of AI solutions across various industries, positioning C3 AI at the forefront of enterprise innovation.

Global Alliances and Market Capture

C3 AI has solidified its global alliances, resulting in a surge in business capabilities. The company closed more than 62% of its agreements through its partner network, highlighting the network's power in driving substantial sales growth. Collaborations with notable enterprises, such as ExxonMobil and the U.S. Department of Defense, have further extended the reach and influence of C3 AI products.

Advancing in Generative AI

The application of generative AI technology has become a focal point for C3 AI, leading to the launch of several pilots and successful transitions of programs into production. The demand for C3 Generative AI solutions has risen significantly, with collaborations with organizations such as Boston Scientific and the National Science Foundation contributing to its robust pipeline.

Innovative Offerings and Patents

C3.ai is committed to maintaining its competitive edge by investing in cutting-edge technologies and solutions. The recent award of a foundational U.S. patent for generative AI agents affirms C3 AI's position as a pioneer in this domain, enabling enterprises to leverage advanced AI capabilities in their operations.

Financial Guidance for the Future

Looking forward, C3 AI has provided guidance for the third quarter fiscal 2025, predicting total revenue between $95.5 million to $100.5 million, and a non-GAAP loss from operations forecast of $(38.6) million to $(46.6) million. This outlook embodies a commitment to sustained growth while navigating market challenges.

Frequently Asked Questions

What were C3 AI's total revenues in Q2 2025?

In Q2 2025, C3 AI reported total revenues of $94.3 million.

How much has C3 AI's subscription revenue increased?

Subscription revenue saw an increase of 22% year-over-year, reaching $81.2 million in Q2 2025.

What partnership is crucial for C3 AI's growth?

The strategic partnership with Microsoft is vital for C3 AI's growth, making it a preferred provider of AI applications on Azure.

What is C3 AI's forecast for future revenues?

C3 AI forecasts total revenues for the third quarter of fiscal 2025 to be between $95.5 million and $100.5 million.

Which sectors is C3 AI targeting with its generative AI offerings?

C3 AI is targeting various sectors, including healthcare, manufacturing, and government with its generative AI solutions.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

One Stop Swap eyes school fundraising for growth

Updated Category News Views 172

Transforming Fundraising with a Marketplace Twist Sometimes the real treasures are not tucked in textbooks but found in cluttered closets and basements. Enter One Stop Swap with a big idea—they're cooking up a fundraising strategy for schools that could shake things up by helping families sell their unused stuff. It's got that grassroots vibe with the potential to carve...

Continue Reading
Lectric Rolls Out Limited-Edition XP4 Ebike Upgrades

Updated Category News Views 51

Pedaling into a New Era of eBikes When the top contender in the American eBike world rolls out something new, you'd better believe it's worth a look. Lectric eBikes has just unwrapped three limited-edition versions of their beloved XP4, revealing a fresh take on a ride already admired by thousands. Let's dig into this new release. What's New with the XP4 This ain't just a...

Continue Reading
Florida Cancer Institute Expands: New Oncologist Joins Team

Updated Category News Views 0

News in the medical world isn't just rattling desks today; it's a purposeful signal for cancer care's transformation. Florida Cancer Specialists & Research Institute (FCS) has beefed up its team, embracing Carlos Barbur, DO, an oncologist who's not just skilled but steeped in disciplines crucial for the health of many. Think of this as another puzzle piece fitting snugly...

Continue Reading
MetaOptics Expands U.S. Reach with ADR Programme

Updated Category News Views 107

A Bold Move into the U.S. Market MetaOptics Ltd, the semiconductor optics dynamo out of Singapore, is kicking up some investment dust with their American Depositary Receipts (ADR) Programme aimed squarely at expanding its U.S. footprint. And let me tell you, in the game of international market expansion, that's no rookie maneuver. Why ADR? Why Now? So, why is MetaOptics...

Continue Reading
Target Hospitality Readies for Q3 2026 Earnings Reveal

Updated Category News Views 42

The Thrill of Earnings Season Every trader worth their salt gets a tingle down the spine come earnings season. There's nothing quite like it—the build-up, the anticipation, the potential payouts. This time, we're zeroing in on Target Hospitality, bearing the ticker NASDAQ: TH. Come November 9, 2026, they're set to unveil what the past quarter had up its sleeve, and like...

Continue Reading
Endeavor & GoPath's Game-Changing Cancer Test Launch

Updated Category News Views 0

Breaking Ground in Prostate Cancer Testing Just when you thought the medical field couldn't shake things up further, Endeavor Health and GoPath Diagnostics swoop in with a new genetic test for prostate cancer. This ain't just any run-of-the-mill test—it's the first of its kind to hit the clinical scene. The focus here is on sorting out which men with prostate cancer are...

Continue Reading
Nanchang Expo Showcases Future of Aviation and Space

Updated Category News Views 242

Aviation Dreams Take Off in Nanchang Not every day you see an expo spanning 30,000 square meters focused on aviation, especially where East meets innovation—Nanchang, the beating heart of Jiangxi Province, China, is where it's all happening this time around. October 31, 2026, saw the city launching not rockets but the 2026 Nanchang Aviation Industry Expo, and folks,...

Continue Reading
TAL's Festive Drinkware Hits Walmart for the Holidays

Updated Category News Views 0

Walmart's Shelves Get Festive with TAL's New Lineup Alright, so we've got TAL rolling out a limited-edition Holiday Coffee Collection exclusively at Walmart stores. You might wonder why a hydration brand is grabbing headlines right now, but listen up—this stuff just hit on November 2 and it's got the sparkle everyone's eyeing this season. What's Inside this Festive...

Continue Reading
Atrium's Heart Therapies: ATR 1072's Promising Data

Updated Category News Views 40

Atrium Therapeutics Strikes a Chord with New Data Tuning into the heartbeats of breakthrough developments, Atrium Therapeutics dropped some fresh, nonclinical insights about their latest contender, ATR 1072. This wasn't just any ordinary announcement; it's like when the market hears whispers of a Fed rate adjustment. The venue? The American Heart Association's 2026...

Continue Reading
Baystate Health Expands: A New Chapter with Mercy

Updated Category News Views 157

Baystate Health Moves Forward with Strategic Integration Well, here's a tale that's as much about legacy as it is about progress. Baystate Health has brought Baystate Mercy Hospital into its fold, blending history with future prospects. This integration, folks, isn't just a merger—it's a downright overhaul of how healthcare operates in Western Massachusetts. We’re...

Continue Reading

Top 5 Most Recently Viewed Articles

Twin Disc Offers Insight at Upcoming Growth Conference

Updated Category News Views 101

Twin Disc's Upcoming Presentation at a Key Conference Twin Disc, Inc. (NASDAQ: TWIN) is gearing up to make a notable appearance at the upcoming Noble Capital Markets Emerging Growth Equity Conference. The event will take place in Boca Raton and is set for a pivotal moment when Chief Financial Officer Jeff Knutson takes the stage to share insights into the company's future...

Continue Reading
Keymed Biosciences Achieves Milestone with Stapokibart Approval

Updated Category News Views 85

Keymed Biosciences Inc. Receives Approval for Stapokibart Keymed Biosciences Inc. (HKEX: 02162) has made impressive advancements in dermatological treatments with the recent marketing approval of Stapokibart. This innovative therapy targets moderate-to-severe atopic dermatitis in adults and has received endorsement from the National Medical Products Administration, the...

Continue Reading
Harnessing AI for Next-Level Value Creation in Tech Firms

Updated Category News Views 215

Harnessing AI for Next-Level Value Creation in Tech Firms In today's fast-paced technological landscape, the integration of artificial intelligence (AI) is reshaping the operational dynamics of companies. Innovators are exploring the potential of AI to redefine services, optimize processes, and create new avenues for revenue generation. In a notable address, an industry...

Continue Reading
CoinShares Reveals Successful Exercise of Share Options

Updated Category News Views 229

CoinShares Executes Employee Share Options with Success CoinShares International Limited (Nasdaq Stockholm Market: CS; US OTCQX: CNSRF) has made a significant announcement regarding its Employee Incentive Plan. Recently, the firm revealed that it has successfully exercised a total of 25,000 options from its Employee Incentive Plan - November 2020 Tranche. This is an...

Continue Reading
EverQuote's Impressive Q3 2025 Performance Highlights

Updated Category News Views 157

EverQuote Reports Strong Growth in Q3 2025 EverQuote, Inc. (Nasdaq: EVER), a prominent player in the online insurance marketplace, has revealed impressive financial results for the third quarter of 2025, showing significant growth across several critical metrics. Revenue surged by 20% year-over-year, reaching $173.9 million, reflecting the company's effective strategies...

Continue Reading